Patent · US Expired

12-aminopyridazinopyrroloisoquinoline compounds

US5614516A · kind A · utility

1Cited by
3References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 7, 1995
Grant dateMar 25, 1997
Priority date
Expiry dateFeb 7, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to new 12-amino-pyridazino-[4',5':3,4]-pyrrolo[2,1-a]isoquinolines of general formula (I) ##STR1## wherein --NR.sub.1 R.sub.2 represents an amino or substituted amino group, and acid addition salts thereof. The new active substances have potential use in pharmaceutical compositions for treating cardiac insufficiency and cerebral metabolic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.